PXMD - PaxMedica, Inc. Stock Price, Fair Value and News

$0.030.00 (0.00%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

PXMD Price Action

Last 30 days

-50%


Last 90 days

-70%


Trailing 12 Months

-94%

PXMD Stock Price

PXMD RSI Chart

MayJunJulAugSepOctNovDec202510203040506070

PXMD Valuation

Market Cap

326.4K

Price/Earnings (Trailing)

-0.02

Price/Free Cashflow

-0.03

PXMD Price/Earnings (Trailing)

Oct2023AprJulOct2024AprJulOct2025-0.6-0.4-0.200.20.4

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PXMD Fundamentals

PXMD Earnings

Earnings (TTM)

-17.7M

Earnings Growth (Yr)

14.01%

Earnings Growth (Qtr)

18.83%

2021202220232024-30M-20M-10M010M

PXMD Profitability

Return on Equity

-1.5K%

Return on Assets

-2.2K%

Free Cashflow Yield

-2.9K%

PXMD Investor Care

Shares Dilution (1Y)

913.13%

Diluted EPS (TTM)

-2.69

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human African trypanosomiasis (HAT). It also develops PAX-102, an intranasal formulation of suramin for neurologic indications; and HAT-301 for the treatment of stage 1 East African HAT. The company has a research collaboration with PoloMar Health to investigate the use of emodin in a clinical program as a potential treatment for patients with autism spectrum disorder The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York.
 CEO
 WEBSITEpaxmedica.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES3

PaxMedica, Inc. Frequently Asked Questions


What is the ticker symbol for PaxMedica, Inc.? What does PXMD stand for in stocks?

PXMD is the stock ticker symbol of PaxMedica, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of PaxMedica, Inc. (PXMD)?

As of Wed Jan 29 2025, market cap of PaxMedica, Inc. is 326.38 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PXMD stock?

You can check PXMD's fair value in chart for subscribers.

Is PaxMedica, Inc. a good stock to buy?

The fair value guage provides a quick view whether PXMD is over valued or under valued. Whether PaxMedica, Inc. is cheap or expensive depends on the assumptions which impact PaxMedica, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PXMD.